PURPOSE: To investigate the potential of magnetic resonance imaging for identification and
quantification of brain iron in healthy subjects, patients with Parkinson disease, and patients …

Objective The objective of this work was to investigate survival, dementia, and genotype‐
phenotype correlations in patients with Parkinson's disease (PD) with and without mutations …

Importance Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause
of genetic Parkinson disease (PD) known to date. The clinical features of …

Switching from oral medications to continuous infusion of levodopa/carbidopa gel reduces
motor complications in advanced Parkinson's disease (PD), but effects on nonmotor …

Objective To determine whether pain is more frequent among people with Parkinson
disease (PD) than among age-matched controls. Design Case-control study. Patients and …

We assessed prospectively clinical and quality of life changes in 9 patients with Parkinson's
disease (PD; H&Y≥ 3) with severe motor fluctuations and dyskinesia who started …

Two small studies reported suboptimal therapy adherence in Parkinson's disease. We
conducted a larger multicenter European study to assess medicine‐taking behavior …

On the basis of Covid-19-induced pulmonary pathological and vascular changes, we
hypothesize that the anti-vascular endothelial growth factor (VEGF) drug bevacizumab might …

Background: Abnormal repetitive behaviors have been reported in Parkinson's disease (PD)
during dopamine replacement therapy (DRT) and associated with individual predisposing …

Parkinson's disease (PD) results in a complex deterioration of motor behavior. Effective
pharmacological or surgical treatments addressing the whole spectrum of both motor and …